ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Supreme Court Rejects Overtime Pay for Drug Reps

By Brent Kendall WASHINGTON--The Supreme Court ruled Monday that drug companies don't have to pay their sales representatives for working overtime hours, a significant win for the pharmaceutical industry. The court, in a 5-4 opinion by Justice Samuel Alito, ruled that drug sales reps fall under a provision of federal labor law that removes overtime-pay requirements for those employed as outside salespeople. The court's ruling rejected arguments by the Department of Labor in favor of overtime pay. The department had argued the outside-sales exemption shouldn't apply because drug reps don't actually sell medicines to doctors but merely promote them. Justice Alito said the Labor Department's position was "quite unpersuasive." The court's five conservative justices formed the majority that ruled against overtime pay. The court's four liberal justices dissented. Monday's decision came in a case involving GlaxoSmithKline PLC (GSK, GSK.LN), which was fighting legal claims from two former salesmen who were seeking overtime pay on behalf of a nationwide class of representatives employed by the drug maker. The case held high stakes for the industry, which spends billions each year promoting drugs to doctors in the U.S. The Pharmaceutical Research and Manufacturers of America, the drug industry's main trade group, had warned in a court brief that classifying sales representatives as eligible for overtime could expose drug companies to retroactive liability and cost the industry billions of dollars. Lower courts had issued conflicting rulings on whether the sales representatives were eligible for overtime pay. Pharmaceutical sales representatives are typically paid a combination of base salary and performance-based commission. In addition, they are usually given a car or an allowance for a car. Many salespeople work long days trying to track down doctors, sometimes waiting until after office hours for a few minutes of face time. The case is Christopher v. SmithKline Beecham, 11-204. Write to Brent Kendall at brent.kendall@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
04/16/201413:42:24U.S. Hot Stocks: Hot Stocks to Watch
04/16/201413:41:44Abbott Labs Profit Falls 31%
04/16/201403:23:12Abbott Laboratories Statement re Current Reports
04/16/201403:23:12Abbott Laboratories Statement re Proxy Materials
04/13/201408:46:33MARKET SNAPSHOT: Google, Intel, IBM Outlooks To Trump Earnings...
02/14/201418:20:25Loeb's Third Point Took New Stakes in T-Mobile, Hertz, BlackBerry...
01/22/201413:24:11Abbott Labs Reports 44% Profit Decline -- Update
01/19/201408:17:14MARKET SNAPSHOT: 'Sloppy' Market Turns To Consumer, Tech Earnings
11/18/201308:56:09AbbVie's Treatment for Hepatitis C Shows Positive Results in...
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:55:36Highbridge Capital Management 3Q 13F: Holdings As -2-
11/15/201308:55:35Highbridge Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201308:53:17D. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201308:53:17D. E. Shaw & Co. LP 3Q 13F: Holdings As Of Sep 30
11/15/201308:22:25Janus Capital Management 3Q 13F: Largest Purchases -2-
11/15/201308:22:24Janus Capital Management 3Q 13F: Largest Purchases
11/15/201308:22:24Janus Capital Management 3Q 13F: Holdings As Of -2-
11/15/201308:22:23Janus Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:59:25Soros Fund Management 3Q 13F: Largest Purchases

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad